Spengler et al. [27] recently reported weak PAD activity in pure, freshly obtained SF from untreated RA patients, which was higher than in SF from OA patients, albeit 100-fold lower than the activity in the presence of DTT-containing citrullination buffer. The gene discussed is PADI4; the disease is rheumatoid arthritis.